BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: integrating clues from the bench and bedside. Eur J Clin Invest. 2011;41:672-678. [PMID: 21158850 DOI: 10.1111/j.1365-2362.2010.02443.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Costa ML. Preeclampsia: Reflections on How to Counsel About Preventing Recurrence. J Obstet Gynaecol Can 2015;37:887-93. [PMID: 26606702 DOI: 10.1016/s1701-2163(16)30023-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Danza Á, Ruiz-Irastorza G, Khamashta M. [Pregnancy in systemic autoimmune diseases: Myths, certainties and doubts]. Med Clin (Barc) 2016;147:306-12. [PMID: 27143525 DOI: 10.1016/j.medcli.2016.03.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
3 Nahal SK, Selmi C, Gershwin ME. Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus. J Autoimmun 2018;93:16-23. [PMID: 30056945 DOI: 10.1016/j.jaut.2018.07.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
4 Park E, Jung H, Hwang J, Kim H, Lee J, Ahn JK, Cha H, Koh E. Pregnancy outcomes in patients with systemic lupus erythematosus: a retrospective review of 62 pregnancies at a single tertiary center in South Korea. Int J Rheum Dis 2014;17:887-97. [DOI: 10.1111/1756-185x.12435] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Alijotas-reig J, Esteve-valverde E, Ferrer-oliveras R, Llurba E, Gris JM. Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review. Clinic Rev Allerg Immunol 2017;53:40-53. [DOI: 10.1007/s12016-016-8596-x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 14.0] [Reference Citation Analysis]
6 Knight CL, Nelson-Piercy C. Management of systemic lupus erythematosus during pregnancy: challenges and solutions. Open Access Rheumatol 2017;9:37-53. [PMID: 28331377 DOI: 10.2147/OARRR.S87828] [Cited by in Crossref: 34] [Cited by in F6Publishing: 8] [Article Influence: 6.8] [Reference Citation Analysis]
7 Taraborelli M, Erkan D. Pregnancy-Related Challenges in Systemic Autoimmune Diseases. J Infus Nurs 2015;38:360-8. [PMID: 26339942 DOI: 10.1097/NAN.0000000000000124] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Fischer-Betz R, Specker C, Brinks R, Aringer M, Schneider M. Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine. Rheumatology (Oxford). 2013;52:1070-1076. [PMID: 23382355 DOI: 10.1093/rheumatology/kes425] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
9 Krasselt M, Baerwald C. Sex, Symptom Severity, and Quality of Life in Rheumatology. Clinic Rev Allerg Immunol 2019;56:346-61. [DOI: 10.1007/s12016-017-8631-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 6.6] [Reference Citation Analysis]
10 Ateka-Barrutia O, Nelson-Piercy C. Connective tissue disease in pregnancy. Clin Med (Lond) 2013;13:580-4. [PMID: 24298106 DOI: 10.7861/clinmedicine.13-6-580] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
11 Braga A, Barros T, Faria R, Marinho A, Carvalheira G, Rocha G, Farinha F, Neves E, Vasconcelos C, Braga J. Systemic lupus erythematosus and pregnancy: A retrospective single-center study of 215 pregnancies from Portugal. Lupus 2021;30:2165-75. [PMID: 34693803 DOI: 10.1177/09612033211050340] [Reference Citation Analysis]
12 Ugarte A, Villar I, Ruiz-Irastorza G. [Management of pregnancy in patients with systemic lupus erythematosus]. Rev Clin Esp 2012;212:491-8. [PMID: 22245369 DOI: 10.1016/j.rce.2011.11.003] [Cited by in Crossref: 6] [Article Influence: 0.6] [Reference Citation Analysis]
13 Alijotas-reig J. Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management. Lupus 2013;22:6-17. [DOI: 10.1177/0961203312465782] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
14 Andreoli L, Fredi M, Nalli C, Reggia R, Lojacono A, Motta M, Tincani A. Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome. Journal of Autoimmunity 2012;38:J197-208. [DOI: 10.1016/j.jaut.2011.11.010] [Cited by in Crossref: 53] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
15 Barbhaiya M, Bermas BL. Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy. Clinical Immunology 2013;149:225-35. [DOI: 10.1016/j.clim.2013.05.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
16 Østensen M. Preconception Counseling. Rheumatic Disease Clinics of North America 2017;43:189-99. [DOI: 10.1016/j.rdc.2016.12.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
17 Canti V, Castiglioni MT, Rosa S, Franchini S, Sabbadini MG, Manfredi AA, Rovere-querini P. Pregnancy outcomes in patients with systemic autoimmunity. Autoimmunity 2011;45:169-75. [DOI: 10.3109/08916934.2011.593600] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
18 Martínez López JA, García Vivar ML, Cáliz R, Freire M, Galindo M, Hernández MV, López Longo FJ, Martínez Taboada V, Pego Reigosa JM, Rubio E, Trujillo E, Vela-Casasempere P. Recommendations for the evaluation and management of patients with rheumatic autoimmune and inflammatory diseases during the reproductive age, pregnancy, postpartum and breastfeeding. Reumatol Clin 2017;13:264-81. [PMID: 27321859 DOI: 10.1016/j.reuma.2016.05.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Pastore DEA, Costa ML, Surita FG. Systemic lupus erythematosus and pregnancy: the challenge of improving antenatal care and outcomes. Lupus 2019;28:1417-26. [PMID: 31551036 DOI: 10.1177/0961203319877247] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
20 Tian X, Li M, Ye Z, Zhang X, Liu S, Wu L, Ma L, Bi L, Zuo X, Sun L, Huang C, Zhao J, Zhang F, Zhao Y, Zeng X; CSTAR co-authors. Related factors of fetal loss in Chinese women with systemic lupus erythematosus: data from Chinese SLE Treatment and Research Group registry IV. Int J Rheum Dis 2015;18:654-60. [PMID: 25546582 DOI: 10.1111/1756-185X.12542] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
21 Wu L, Jiang XQ, Xiong YQ, Lin XM. Muscle weakness of the lower limbs after epidural anesthesia in a pregnant woman with undiscovered systemic lupus erythematosus. Chin Med J (Engl) 2020;133:621-2. [PMID: 32032082 DOI: 10.1097/CM9.0000000000000665] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Rajaei E, Shahbazian N, Rezaeeyan H, Mohammadi AK, Hesam S, Zayeri ZD. The effect of lupus disease on the pregnant women and embryos: a retrospective study from 2010 to 2014. Clin Rheumatol 2019;38:3211-5. [PMID: 31352646 DOI: 10.1007/s10067-019-04682-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
23 Kroese SJ, Abheiden CNH, Blomjous BS, van Laar JM, Derksen RWHM, Bultink IEM, Voskuyl AE, Lely AT, de Boer MA, de Vries JIP, Fritsch-Stork RDE. Maternal and Perinatal Outcome in Women with Systemic Lupus Erythematosus: A Retrospective Bicenter Cohort Study. J Immunol Res 2017;2017:8245879. [PMID: 29094052 DOI: 10.1155/2017/8245879] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
24 Cavallasca JA, Costa CA, Maliandi MDR, Musuruana JL. Hot topics in lupus pregnancy. World J Rheumatol 2013; 3(3): 32-39 [DOI: 10.5499/wjr.v3.i3.32] [Reference Citation Analysis]
25 Polić A, Običan SG. Pregnancy in systemic lupus erythematosus. Birth Defects Res 2020;112:1115-25. [PMID: 32902202 DOI: 10.1002/bdr2.1790] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Siekierka-Harreis M, Rump LC. [Pregnancy and kidney diseases]. Internist (Berl) 2011;52:1167-77. [PMID: 21935640 DOI: 10.1007/s00108-011-2824-5] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
27 Pan ML, Chen LR, Tsao HM, Chen KH. Prepregnancy Endocrine, Autoimmune Disorders and the Risks of Gestational Hypertension-Preeclampsia in Primiparas: A Nationwide Population-Based Study in Taiwan. Int J Environ Res Public Health 2020;17:E3657. [PMID: 32456015 DOI: 10.3390/ijerph17103657] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
28 Shaharir SS, Mohamed Said MS, Mohd R, Abdul Cader R, Mustafar R, Abdul Rahman R. Predictors of SLE relapse in pregnancy and post-partum among multi-ethnic patients in Malaysia. PLoS One 2019;14:e0222343. [PMID: 31539383 DOI: 10.1371/journal.pone.0222343] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
29 Ateka-Barrutia O, Khamashta MA. The challenge of pregnancy for patients with SLE. Lupus 2013;22:1295-308. [PMID: 24098002 DOI: 10.1177/0961203313504637] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
30 Chen D, Lao M, Cai X, Li H, Zhan Y, Wang X, Zhan Z. Hypertensive disorders of pregnancy associated with adverse pregnant outcomes in patients with systemic lupus erythematosus: a multicenter retrospective study. Clin Rheumatol 2019;38:3501-9. [PMID: 31377919 DOI: 10.1007/s10067-019-04696-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
31 Saavedra Salinas MÁ, Barrera Cruz A, Cabral Castañeda AR, Jara Quezada LJ, Arce-salinas CA, Álvarez Nemegyei J, Fraga Mouret A, Orozco Alcalá J, Salazar Páramo M, Cruz Reyes CV, Andrade Ortega L, Vera Lastra OL, Mendoza Pinto C, Sánchez González A, Cruz Cruz PDR, Morales Hernández S, Portela Hernández M, Pérez Cristóbal M, Medina García G, Hernández Romero N, Velarde Ochoa MDC, Navarro Zarza JE, Portillo Díaz V, Vargas Guerrero A, Goycochea Robles MV, García Figueroa JL, Barreira Mercado E, Amigo Castañeda MC. Guías de práctica clínica para la atención del embarazo en mujeres con enfermedades reumáticas autoinmunes del Colegio Mexicano de Reumatología. Parte I. Reumatología Clínica 2015;11:295-304. [DOI: 10.1016/j.reuma.2014.11.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
32 Yamamoto Y, Aoki S. Systemic lupus erythematosus: strategies to improve pregnancy outcomes. Int J Womens Health 2016;8:265-72. [PMID: 27468250 DOI: 10.2147/IJWH.S90157] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
33 Braga A, Barros T, Faria R, Marinho A, Rocha G, Farinha F, Neves E, Vasconcelos C, Braga J. Systemic Lupus Erythematosus and Pregnancy: a Portuguese Case-Control Study. Clin Rev Allergy Immunol 2021. [PMID: 34519994 DOI: 10.1007/s12016-021-08893-y] [Reference Citation Analysis]
34 de Jesus GR, Mendoza-Pinto C, de Jesus NR, Dos Santos FC, Klumb EM, Carrasco MG, Levy RA. Understanding and Managing Pregnancy in Patients with Lupus. Autoimmune Dis 2015;2015:943490. [PMID: 26246905 DOI: 10.1155/2015/943490] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
35 Marder W. Update on pregnancy complications in systemic lupus erythematosus. Curr Opin Rheumatol 2019;31:650-8. [PMID: 31464707 DOI: 10.1097/BOR.0000000000000651] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
36 Wang M, Kong X, Xie Y, He C, Wang T, Zhou H. Role of TLR‑4 in anti‑β2‑glycoprotein I‑induced activation of peritoneal macrophages and vascular endothelial cells in mice. Mol Med Rep 2019;19:4353-63. [PMID: 30942412 DOI: 10.3892/mmr.2019.10084] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Fredi M, Gregorini G, Zatti S, Lojacono A, Tincani A. Identifying and managing lupus nephritis during pregnancy. Expert Opinion on Orphan Drugs 2016;4:1021-31. [DOI: 10.1080/21678707.2016.1228452] [Reference Citation Analysis]
38 Zusman EZ, Sayre EC, Aviña-zubieta JA, De Vera MA. Patterns of medication use before, during and after pregnancy in women with systemic lupus erythematosus: a population-based cohort study. Lupus 2019;28:1205-13. [DOI: 10.1177/0961203319863111] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]